Vera Therapeutics, Inc. (VERA) has a consensus analyst rating of Buy, based on 14 analysts covering the stock. Of those, 13 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for VERA is $77.60, representing a +74.9% upside from the current price of $44.36. Price targets range from a low of $33.00 to a high of $97.00.
